Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
Once approved, new test will help laboratories increase testing capacity and decrease turnaround time for results
02-Nov-2020 -
Merck announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Mammoth’s high-throughput systems will be compatible with both nasal swab and ...
Coronavirus testing
coronaviruses
CRISPR
+3